Literature DB >> 25083308

A case report of HCC cutaneous metastasis.

Divina Traficante1, Pasquale Assalone1, Federica Tomei1, Franco Calista1, Jessica Falleti1, Enrico Caranci1, Liberato Di Lullo1.   

Abstract

INTRODUCTION: Hepatocellular carcinoma (HCC) is one of the most common solid tumors in the world. HCC muscle and cutaneous metastases are rare and can occur by hematogenous spread or following surgical procedures performed for diagnostic or therapeutic aims. CASE STUDY: We present a 47-year-old man underwent liver biopsy followed by surgical resection for moderately differentiated HCC in January 1999. In February 2010 the patient presented with HCC cutaneous metastases in the surgical scare and with HCC metastases of the right abdominal rectus muscle. En bloc tumor resection with the right abdominal rectus muscle was performed. In March 2011 the patient underwent resection of a locoregional muscle relapse. In November 2011 we started Sorafenib for intraepatic recurrence. DISCUSSION: This case suggests that in the follow-up of patients who underwent surgical resection or diagnostic and therapeutic procedures for HCC should be considered the possibility of abdominal wall metastasis even after many years, particularly in the cases with favorable evolution.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); cutaneous metastases; muscle metastases; seeding

Year:  2014        PMID: 25083308      PMCID: PMC4110500          DOI: 10.3978/j.issn.2078-6891.2014.021

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  4 in total

1.  Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma.

Authors:  T Livraghi; S Lazzaroni; F Meloni; L Solbiati
Journal:  Br J Surg       Date:  2005-07       Impact factor: 6.939

2.  Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma.

Authors:  Jun Imamura; Ryosuke Tateishi; Shuichiro Shiina; Eriko Goto; Takahisa Sato; Takamasa Ohki; Ryota Masuzaki; Tadashi Goto; Hideo Yoshida; Fumihiko Kanai; Keisuke Hamamura; Shuntaro Obi; Haruhiko Yoshida; Masao Omata
Journal:  Am J Gastroenterol       Date:  2008-12       Impact factor: 10.864

3.  Subcutaneous tumor seeding following needle core biopsy of hepatocellular carcinoma.

Authors:  Leslie R Rowe; Sean J Mulvihill; Lyska Emerson; Evelyn V Gopez
Journal:  Diagn Cytopathol       Date:  2007-11       Impact factor: 1.582

Review 4.  Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC.

Authors:  R Stigliano; L Marelli; D Yu; N Davies; D Patch; A K Burroughs
Journal:  Cancer Treat Rev       Date:  2007-05-18       Impact factor: 12.111

  4 in total
  4 in total

1.  A case of hepatocellular carcinoma with long-term survival by multidisciplinary treatment for cranial and skeletal muscle metastases.

Authors:  Noriyuki Akutsu; Yujiro Kawakami; Yasunao Numata; Takehiro Hirano; Kohei Wagatsuma; Keisuke Ishigami; Shigeru Sasaki; Hiroshi Nakase
Journal:  Clin J Gastroenterol       Date:  2022-07-14

2.  Extrahepatic metastasis of hepatocellular carcinoma to the paravertebral muscle: A case report.

Authors:  Kazuhiro Takahashi; Krishna G Putchakayala; Mohamed Safwan; Dean Y Kim
Journal:  World J Hepatol       Date:  2017-08-08

3.  Rare Site Hepatocellular Carcinoma Metastasis.

Authors:  Enrique Boldo; Ana Santafe; Araceli Mayol; Rafael Lozoya; Alba Coret; Diana Escribano; Carlos Fortea-Sanchis; Andres Muñoz; Juan Carlos Pastor; Guillermo Perez de Lucia; Nuria Bosch
Journal:  J Hepatocell Carcinoma       Date:  2020-03-25

Review 4.  Muscular Metastasis of Hepatocellular Carcinoma: Case Report and Literature Review.

Authors:  Akihiro Nakayama; Jun Arai; Yumi Otoyama; Ikuya Sugiura; Yoko Nakajima; Atsushi Kajiwara; Yuki Ichikawa; Shojiro Uozumi; Yuu Shimozuma; Manabu Uchikoshi; Masashi Sakaki; Sakiko Tazawa; Eisuke Shiozawa; Toshiko Yamochi; Masafumi Takimoto; Hitoshi Yoshida
Journal:  Intern Med       Date:  2021-07-03       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.